Page last updated: 2024-08-23

methyldopa and Basal Ganglia Diseases

methyldopa has been researched along with Basal Ganglia Diseases in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davydova, ON; Krendal', FP; Kudrin, AN	1
Mayer, K	1
Demontis, G; Rosati, G; Sechi, GP	1
Chouinard, G; Serrano, PM; Tetreault, L	1
Calne, DB; Reid, JL	1
Cole, JO; Kazamatsuri, H	1

Reviews

1 review(s) available for methyldopa and Basal Ganglia Diseases

Article	Year
Antiparkinsonian drugs: pharmacological and therapeutic aspects. Drugs, 1972, Volume: 4, Issue:1 Topics: Acetylcholine; Adrenergic beta-Antagonists; Amantadine; Amphetamine; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Histamine H1 Antagonists; Humans; Mental Disorders; Methyldopa; Movement Disorders; Norepinephrine; Parasympatholytics; Serotonin; Synaptic Transmission	1972

Article

Year

Antiparkinsonian drugs: pharmacological and therapeutic aspects.

Drugs, 1972, Volume: 4, Issue:1

Topics: Acetylcholine; Adrenergic beta-Antagonists; Amantadine; Amphetamine; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Histamine H1 Antagonists; Humans; Mental Disorders; Methyldopa; Movement Disorders; Norepinephrine; Parasympatholytics; Serotonin; Synaptic Transmission

1972

Other Studies

5 other study(ies) available for methyldopa and Basal Ganglia Diseases

Article	Year
[Pharmacologic incompatibility of neuroleptics and tranquilizers with other medicines]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1977, Volume: 77, Issue:4 Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cardiac Glycosides; Cats; Drug Interactions; Haloperidol; Humans; Hypertension; Lithium; Methyldopa; Methylphenidate; Monoamine Oxidase Inhibitors; Parasympatholytics; Phenothiazines; Propranolol; Tranquilizing Agents	1977
[Neurogenic symptoms for the early diagnosis of adverse drug effects]. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1976, Volume: 82 Pt 1 Topics: Anti-Bacterial Agents; Anticoagulants; Basal Ganglia Diseases; Chloroquine; Cortisone; Depression; Drug-Related Side Effects and Adverse Reactions; Glucocorticoids; Hematoma; Humans; Hypokalemia; Methyldopa; Muscular Atrophy; Nervous System Diseases; Neurologic Manifestations; Neuromuscular Junction; Paralysis; Poisoning; Secologanin Tryptamine Alkaloids; Spinal Cord Compression; Tranquilizing Agents	1976
Relationship between Meige syndrome and alpha-methyldopa-induced parkinsonism. Neurology, 1985, Volume: 35, Issue:11 Topics: Aged; Basal Ganglia Diseases; Female; Humans; Male; Meige Syndrome; Methyldopa; Parkinson Disease, Secondary	1985
Potentiation of haloperidol by -methyldopa in the treatment of schizophrenic patients. Current therapeutic research, clinical and experimental, 1973, Volume: 15, Issue:7 Topics: Adult; Antiparkinson Agents; Basal Ganglia Diseases; Blood Pressure; Body Weight; Drug Synergism; Female; Haloperidol; Humans; Male; Methyldopa; Psychiatric Status Rating Scales; Pulse; Reticulocytes; Schizophrenia; Time Factors; Vertigo	1973
Treatment of tardive dyskinesia. 3. Clinical efficacy of a dopamine competing agent, methyldopa. Archives of general psychiatry, 1972, Volume: 27, Issue:6 Topics: Basal Ganglia Diseases; Blood Pressure; Evaluation Studies as Topic; Female; Humans; Male; Methyldopa; Middle Aged; Movement Disorders; Psychoses, Substance-Induced; Schizophrenia; Tranquilizing Agents	1972